Skip to main content
Journal ArticleOPEN ACCESS

Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study

  • Schmoele-Thoma B
  • Zareba A
  • Jiang Q
  • et al.
New England Journal of Medicine (2022) 386(25) 2377-2386
DOI: 10.1056/nejmoa2116154
82Citations
Citations of this article
123Readers
Mendeley users who have this article in their library.

Abstract

Abstract Background Although human respiratory syncytial virus (RSV) is an important cause of illness and death in older adults, no RSV vaccine has been licensed. Methods In a phase 2a study, we ra...

Cite

CITATION STYLE

APA

Schmoele-Thoma, B., Zareba, A. M., Jiang, Q., Maddur, M. S., Danaf, R., Mann, A., … Swanson, K. A. (2022). Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study. New England Journal of Medicine, 386(25), 2377–2386. https://doi.org/10.1056/nejmoa2116154

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free